PREVENTION OF TYPE 2 DIABETES
Open Access
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Medical Clinics of North America
- Vol. 82 (4) , 805-821
- https://doi.org/10.1016/s0025-7125(05)70025-0
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Induction of Uncoupling Protein-2 mRNA by Troglitazone in the Pancreatic Islets of Zucker Diabetic Fatty RatsBiochemical and Biophysical Research Communications, 1997
- Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.Journal of Clinical Investigation, 1997
- Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione TroglitazoneDiabetes Care, 1997
- The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose ToleranceDiabetes Care, 1996
- Dietary Fat Predicts Conversion From Impaired Glucose Tolerance to NIDDM: The San Luis Valley Diabetes StudyDiabetes Care, 1994
- Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance: the Honolulu Heart ProgramJournal of Internal Medicine, 1993
- Can Life‐styles of Subjects With Impaired Glucose Tolerance Be Changed? A Feasibility StudyDiabetic Medicine, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- The Natural History of Impaired Glucose Tolerance in the Pima IndiansNew England Journal of Medicine, 1988
- Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patientsDiabetologia, 1978